AAcademia Sinica

Taiwan research head apologizes as he admits selling off OBI Pharma shares

laptop against white background

As promised, we bring you the new and improved FiercePharma


Baxter, Torrent bidding for India’s Gland Pharma: Reuters

Europe map

WuXi’s Crelux acquisition to boost European expansion

WuXi AppTec has bought Germany-based drug discovery provider Crelux as the Chinese company looks to move more deeply into Europe.

Brain imaging

Eisai gains Philippines approval for Aricept in new license

Seventeen years after the Philippines first approved Eisai and Pfizer’s Alzheimer’s drug Aricept, the country has now granted a new license for patients with…


Touts thwart top-level reforms at China's public hospitals

China's repeated efforts to reform the public hospital system by getting patients to smaller clinics first and curbing graft in a system under intense…


Quality issues not behind sight loss in off-label Avastin use in India

Roche has checked a batch of Avastin (bevacizumab) in India linked to partial loss of sight for 15 patients and did not find any quality-related issues, though…

Seoul, Korea

Dong-A ST gains Korean rights to potential NASH candidate

Dong-A ST has signed a new licensing deal with Tobira Therapeutics that will allow it to research and sell the California company's fatty liver disease…

A sequencing room at BGI Hong Kong

BGI's latest listing plan targets A-shares in Mainland China

Shenzhen-based genomics powerhouse BGI is now said to be looking at Mainland China to launch an initial public offering (IPO) by the end of 2016, FinanceAsia…


AZ, BMS get a breather as India yanks CL appeals

Compulsory license applications in India have been quietly withdrawn as firms in the space suggest at least a higher bar has been set.

Germany's Merck has sold Bangalore reagents, peptides, biopharmaceuticals manufacturer GeNei back to its founder S Chandrashekaran a year after shuttering…

Japan's Kaketsuken is in talks to sell its vaccines unit to Tokyo-based Astellas Pharma, Nikkei Asian Review reports, as it struggles to recover from…

Beijing-based CANbridge Life Sciences has sent the Taiwan FDA an Investigational New Drug application for candidate CAN-008 aimed at brain cancer…